{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:35:58Z","timestamp":1788467758892,"version":"build-2803163510"},"reference-count":101,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bbadis.2018.07.025","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T22:54:00Z","timestamp":1533941640000},"page":"954-964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Animal models of cholestasis: An update on inflammatory cholangiopathies"],"prefix":"10.1016","volume":"1865","author":[{"given":"Valeria","family":"Mariotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Cadamuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Spirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Fiorotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Strazzabosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2018.07.025_bb0005","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1097\/01.mcg.0000155549.29643.ad","article-title":"Pathophysiology of cholangiopathies","volume":"39","author":"Strazzabosco","year":"2005","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0010","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.bbadis.2017.08.020","article-title":"Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma","volume":"1864","author":"Chung","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep4.1013","article-title":"Update on pharmacotherapies for cholestatic liver disease","volume":"1","author":"Ali","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0025","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/hep.510280601","article-title":"Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications","volume":"28","author":"Beuers","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0030","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0035","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/ncb437","article-title":"The mouse ascending: perspectives for human-disease models","volume":"9","author":"Rosenthal","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0040","series-title":"Building a Better Mouse: One Hundred Years of Genetics and Biology","author":"M. HCI","year":"2007"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0045","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/path.1700350512","article-title":"Ligation of the common bile duct","volume":"35","author":"Cameron","year":"1932","journal-title":"J. Path. Bact. Lond."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0050","first-page":"170","article-title":"Mouse models of human disease: an evolutionary perspective","volume":"2016","author":"Perlman","year":"2016","journal-title":"Evol. Med. Public Health"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2613.2008.00597.x","article-title":"Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation","volume":"89","author":"Geerts","year":"2008","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S0102-86502012000800013","article-title":"Review of experimental models for inducing hepatic cirrhosis by bile duct ligation and carbon tetrachloride injection","volume":"27","author":"Marques","year":"2012","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0065","article-title":"Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis","volume":"96","author":"Tag","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0070","first-page":"651","article-title":"Bile duct ligation: step-by-step to cholangiocyte inflammatory tumorigenesis","volume":"22","author":"Aller","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0075","doi-asserted-by":"crossref","first-page":"G323","DOI":"10.1152\/ajpgi.00394.2009","article-title":"Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis","volume":"298","author":"Popov","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0080","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbadis.2017.06.027","article-title":"Animal models of biliary injury and altered bile acid metabolism","volume":"1864","author":"Mariotti","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0085","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/j.2040-4603.2013.tb00519.x","article-title":"Bile formation and secretion","volume":"3","author":"Boyer","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0090","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.3748\/wjg.14.5641","article-title":"Physiology of bile secretion","volume":"14","author":"Esteller","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0095","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","article-title":"Molecular pathogenesis of cholestasis","volume":"339","author":"Trauner","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0100","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/hep.22926","article-title":"Differentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation","volume":"50","author":"Strazzabosco","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0105","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ar.20664","article-title":"Functional anatomy of normal bile ducts","volume":"291","author":"Strazzabosco","year":"2008","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0110","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/gast.2003.50100","article-title":"Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes","volume":"124","author":"Spirli","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0115","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1242\/jeb.01440","article-title":"Hypotonicity induced K+ and anion conductive pathways activation in eel intestinal epithelium","volume":"208","author":"Lionetto","year":"2005","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0922-4106(92)90064-3","article-title":"Separation and purification by two-dimensional gel electrophoresis of a 52\u201354\u202fkDa bumetanide binding protein from rat liver plasma membranes","volume":"226","author":"Honscha","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0125","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.3748\/wjg.14.7059","article-title":"Aquaporins: their role in cholestatic liver disease","volume":"14","author":"Lehmann","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0130","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0135","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J. Hepatol."},{"issue":"10139","key":"10.1016\/j.bbadis.2018.07.025_bb0140","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0145","doi-asserted-by":"crossref","first-page":"G449","DOI":"10.1152\/ajpgi.00199.2012","article-title":"Animal models of chronic liver diseases","volume":"304","author":"Liu","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","author":"Ji","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2013.03.015","article-title":"Update on primary sclerosing cholangitis","volume":"59","author":"Karlsen","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0160","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bpg.2010.07.005","article-title":"Primary sclerosing cholangitis","volume":"24","author":"Karlsen","year":"2010","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2015.08.012","article-title":"The gut-liver axis in primary sclerosing cholangitis","volume":"20","author":"Eksteen","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0170","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0175","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1053\/j.gastro.2011.06.052","article-title":"Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-kappaB-mediated inflammatory response in mice","volume":"141","author":"Fiorotto","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7861\/clinmedicine.4-2-173","article-title":"Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease","volume":"4","author":"Eksteen","year":"2004","journal-title":"Clin. Med. (Lond.)"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0185","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1172\/JCI117658","article-title":"Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse","volume":"95","author":"Oude Elferink","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"Fickert","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0200","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","article-title":"Mdr2 (Abcb4)\u2212\/\u2212 mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes","volume":"43","author":"Popov","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0205","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.95.1.282","article-title":"Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis","volume":"95","author":"de Vree","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","article-title":"MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes","volume":"27","author":"Trauner","year":"2007","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0031-1272831","article-title":"Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings","volume":"31","author":"Morotti","year":"2011","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0220","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.22891","article-title":"Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2\u2212\/\u2212 mice","volume":"49","author":"Halilbasic","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0225","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3)(\u2212) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0230","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0235","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1194\/jlr.M044420","article-title":"Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice","volume":"55","author":"Cheng","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0240","doi-asserted-by":"crossref","first-page":"14486","DOI":"10.1074\/jbc.M110.116004","article-title":"Regulation of bile acid synthesis by fat-soluble vitamins A and D","volume":"285","author":"Schmidt","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0245","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12072-014-9548-2","article-title":"Vitamin D modulates biliary fibrosis in ABCB4-deficient mice","volume":"8","author":"Hochrath","year":"2014","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0250","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.28274","article-title":"Integrin alphavbeta6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis","volume":"63","author":"Peng","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0255","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2007.11.021","article-title":"Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies","volume":"48","author":"Popov","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0260","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gutjnl-2016-312473","article-title":"Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal","volume":"66","author":"Ikenaga","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29898","article-title":"Blocking H1\/H2 histamine receptors inhibits damage\/fibrosis in Mdr2(\u2212\/\u2212) mice and human cholangiocarcinoma tumorigenesis","author":"Kennedy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0270","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2017-314553","article-title":"Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(\u2212\/\u2212) mice by modulating composition, signalling and excretion of faecal bile acids","author":"Fuchs","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0275","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.gastro.2007.04.007","article-title":"Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis","volume":"133","author":"Marzioni","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0280","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/01926230590522095","article-title":"Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer","volume":"33","author":"Calvisi","year":"2005","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0285","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1541-7786.MCR-07-0172","article-title":"Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice","volume":"5","author":"Katzenellenbogen","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0290","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1172\/JCI77995","article-title":"Hepatocellular carcinoma originates from hepatocytes and not from the progenitor\/biliary compartment","volume":"125","author":"Mu","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"1_supplement","key":"10.1016\/j.bbadis.2018.07.025_bb0295","article-title":"A novel murine model of primary sclerosing cholangitis associated inflammatory bowel disease","volume":"31","author":"Battista","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0300","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0016-5085(99)70464-6","article-title":"Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria","volume":"117","author":"Meerman","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0305","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jhep.2014.02.006","article-title":"Characterization of animal models for primary sclerosing cholangitis (PSC)","volume":"60","author":"Fickert","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0310","doi-asserted-by":"crossref","first-page":"175265","DOI":"10.1155\/2014\/175265","article-title":"Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity","volume":"2014","author":"Erkes","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0315","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0168-8278(95)80432-3","article-title":"Induction of chronic cholangitis in the rat by trinitrobenzenesulfonic acid","volume":"22","author":"Mourelle","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0320","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0168-8278(00)80116-6","article-title":"A novel rat model of chronic fibrosing cholangitis induced by local administration of a hapten reagent into the dilated bile duct is associated with increased TNF-alpha production and autoantibodies","volume":"33","author":"Orth","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0325","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-3083.2003.01335.x","article-title":"Long-term evaluation of a rat model of chronic cholangitis resembling human primary sclerosing cholangitis","volume":"58","author":"Goetz","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0330","doi-asserted-by":"crossref","first-page":"12598","DOI":"10.1021\/bi050943e","article-title":"Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice","volume":"44","author":"Lam","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0335","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1073\/pnas.98.4.2011","article-title":"Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis","volume":"98","author":"Wang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0340","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.3748\/wjg.v18.i36.4985","article-title":"Novel insight into mechanisms of cholestatic liver injury","volume":"18","author":"Woolbright","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0345","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/jps.23584","article-title":"An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters","volume":"102","author":"Yang","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0350","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/hep.21143","article-title":"Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases","volume":"43","author":"Fabris","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0355","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0016-5085(90)90833-M","article-title":"Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth","volume":"98","author":"Lichtman","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0360","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jhep.2012.01.019","article-title":"Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease","volume":"56","author":"Fouts","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0365","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2007.08.017","article-title":"Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system","volume":"131","author":"Garrett","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0370","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.27927","article-title":"Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis","volume":"63","author":"Tabibian","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0375","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12072-017-9830-1","article-title":"Primary biliary cholangitis: a comprehensive overview","volume":"11","author":"Lleo","year":"2017","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0380","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00281-009-0164-5","article-title":"Primary biliary cirrhosis","volume":"31","author":"Hohenester","year":"2009","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0385","first-page":"1495","article-title":"Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid","volume":"22","author":"Kuiper","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0390","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0395","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pathol-020712-164014","article-title":"The immunobiology and pathophysiology of primary biliary cirrhosis","volume":"8","author":"Hirschfield","year":"2013","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0400","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1038\/ncomms9019","article-title":"International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways","volume":"6","author":"Cordell","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0405","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2249.1996.d01-767.x","article-title":"Reduction in serum levels of antimitochondrial (M2) antibodies following immunoglobulin therapy in severe combined immunodeficient (SCID) mice reconstituted with lymphocytes from patients with primary biliary cirrhosis (PBC)","volume":"105","author":"Abedi","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0410","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.20051911","article-title":"NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis","volume":"203","author":"Irie","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0415","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4049\/jimmunol.1001597","article-title":"CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease","volume":"186","author":"Yang","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0420","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/hep.21385","article-title":"IL-2 receptor alpha(\u2212\/\u2212) mice and the development of primary biliary cirrhosis","volume":"44","author":"Wakabayashi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0425","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.22591","article-title":"Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(\u2212\/\u2212) mice","volume":"49","author":"Hsu","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0430","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.4049\/jimmunol.1300397","article-title":"Truncated form of TGF-betaRII, but not its absence, induces memory CD8+ T cell expansion and lymphoproliferative disorder in mice","volume":"190","author":"Ishigame","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0435","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.22052","article-title":"Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis","volume":"47","author":"Chuang","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0440","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","article-title":"RAG-1-deficient mice have no mature B and T lymphocytes","volume":"68","author":"Mombaerts","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0445","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.23132","article-title":"Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice","volume":"50","author":"Yoshida","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074225","article-title":"Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis","volume":"8","author":"Kawata","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0455","first-page":"1379","article-title":"X-linked lymphoreticular disease in the scurfy (sf) mutant mouse","volume":"138","author":"Godfrey","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0460","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0465","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","article-title":"Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis","volume":"134","author":"Salas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0470","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cellimm.2014.05.006","article-title":"The PD-1\/PD-Ls pathway and autoimmune diseases","volume":"290","author":"Dai","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0475","doi-asserted-by":"crossref","first-page":"28588","DOI":"10.18632\/oncotarget.5665","article-title":"CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b\u2212\/\u2212 mice favoring autoimmune cholangitis","volume":"6","author":"Concepcion","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0480","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.4049\/jimmunol.174.9.5874","article-title":"Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid","volume":"174","author":"Amano","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0485","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.4049\/jimmunol.170.10.5326","article-title":"Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies","volume":"170","author":"Leung","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0490","doi-asserted-by":"crossref","first-page":"15246","DOI":"10.1038\/s41598-017-15661-6","article-title":"A mouse model of autoimmune cholangitis via syngeneic bile duct protein immunization","volume":"7","author":"Ma","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0495","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hep.28641","article-title":"Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance","volume":"64","author":"Bae","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.025_bb0500","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1440-1827.2001.01223.x","article-title":"Spontaneous occurrence of chronic non-suppurative destructive cholangitis and antimitochondrial autoantibodies in MRL\/lpr mice: possible animal model for primary biliary cirrhosis","volume":"51","author":"Tsuneyama","year":"2001","journal-title":"Pathol. Int."},{"key":"10.1016\/j.bbadis.2018.07.025_bb0505","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/00313020220131318","article-title":"A possible mouse model for spontaneous cholangitis: serological and histological characteristics of MRL\/lpr mice","volume":"34","author":"Ohba","year":"2002","journal-title":"Pathology"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918302746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918302746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:45:56Z","timestamp":1760417156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918302746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0925443918302746"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.025","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models of cholestasis: An update on inflammatory cholangiopathies","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}